ClinicalTrials.gg
DrugBiological

Octagam clinical trials

A product of Immunoglobulins, Intravenous; its studies count on that page too.

studies test it
9
open now
0
in phase 3
6
first study started
2002

How each study uses Octagam is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
21 May 2004 · Octagam · BLA 125062 (FDA, Purple Book)
European Union
19 Jan 2006 · Kiovig · EMEA/H/C/000628 (EMA; as Immunoglobulins, Intravenous)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Octagam 10%
6
Octagam
2
IVIG
2

Studies by the year they started

9 studies that test it; most in 2009 (2)

Studies that test Octagam, by start year
YearStudies
20021
20061
20071
20092
20171
20181
20202

By phase

A phase 1/2 study counts in both.

Phase 2
3
Phase 3
6
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 5 · Other 4

Octapharma (5) · George Sakoulas, MD (1) · Sutter Health (1) · Oslo University Hospital (1) · University Hospital, Bonn (1)

Often tested with

Tested in the same studies.

Tacrolimus (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Octagam is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 9